{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:28:57Z","timestamp":1789824537418,"version":"4.0.1"},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3_suppl_3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1998,9]]},"DOI":"10.1212\/wnl.51.3_suppl_3.s62","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:36:05Z","timestamp":1336916165000},"source":"Crossref","is-referenced-by-count":159,"title":["The role of inflammation after acute stroke"],"prefix":"10.1212","volume":"51","author":[{"given":"Thomas J.","family":"DeGraba","sequence":"first","affiliation":[{"name":"From the Clinical Investigation Section (Stroke Branch), National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","first-page":"C","volume":"263","year":"1992","unstructured":"Benveniste EN. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol 1992;263:C1-16.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_3_2","first-page":"2","volume":"71","year":"1996","unstructured":"Hallenbeck JM. Inflammatory reactions at the blood-endothelial interface in acute stroke. Adv Neurol 1996;71:281-297.","journal-title":"Adv Neurol"},{"key":"e_1_3_2_4_2","first-page":"2","volume":"40","year":"1997","unstructured":"Rothwell NJ, Loddick SA, Stroemer P. Interleukins and cerebral ischaemia. Int Rev Neurobiol 1997;40:281-298.","journal-title":"Int Rev Neurobiol"},{"key":"e_1_3_2_5_2","first-page":"1","volume":"269","year":"1993","unstructured":"Dinarello CA, Gelfand JA, Wolff SM. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 1993;269:1829-1835.","journal-title":"JAMA"},{"key":"e_1_3_2_6_2","first-page":"2","volume":"10","year":"1990","unstructured":"Choi DW. Cerebral hypoxia: some new approaches and unanswered questions. J Neurosci 1990;10:2493-2501.","journal-title":"J Neurosci"},{"key":"e_1_3_2_7_2","first-page":"3","volume":"59","year":"1996","unstructured":"Kristi\u00e1n T, Siesj\u00f6 BK. Calcium-related damage in ischemia. Life Sci 1996;59:357-367.","journal-title":"Life Sci"},{"key":"e_1_3_2_8_2","first-page":"7","volume":"163","year":"1986","unstructured":"Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986;163:740-745.","journal-title":"J Exp Med"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.25.1.1"},{"key":"e_1_3_2_10_2","first-page":"6","volume":"160","year":"1984","unstructured":"Bevilacqua MP, Pober JS, Majeau GR, Cotran R, Gimbrone MA Jr. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 1984;160:618-623.","journal-title":"J Exp Med"},{"key":"e_1_3_2_11_2","first-page":"3","volume":"83","year":"1986","unstructured":"Nawroth PP, Handley DA, Esmon CT, Stern DM. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci USA 1986;83:3460-3464.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_2_12_2","first-page":"7","volume":"11","year":"1993","unstructured":"Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 1993;11:767-804.","journal-title":"Annu Rev Immunol"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116185"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90873-7"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0196-7"},{"key":"e_1_3_2_16_2","first-page":"4","volume":"23","year":"1997","unstructured":"Mattson MP, Barger SW, Furukawa K, et al. Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease. Brain Res Brain Res Rev 1997;23:47-61.","journal-title":"Brain Res Brain Res Rev"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02858503"},{"key":"e_1_3_2_18_2","first-page":"2","volume":"45","year":"1996","unstructured":"Betz AL, Schielke GP, Yang GY. Interleukin-1 in cerebral ischemia. Keio J Med 1996;45:230-237.","journal-title":"Keio J Med"},{"key":"e_1_3_2_19_2","first-page":"1","volume":"147","year":"1995","unstructured":"Garcia JH, Liu KF, Relton JK. Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am J Pathol 1995;147:1477-1486.","journal-title":"Am J Pathol"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.28.1.1"},{"key":"e_1_3_2_21_2","first-page":"4","volume":"218","year":"1996","unstructured":"Dawson D, Martin D, Hallenbeck JM. Inhibition of tumor necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rat. Neurosci Lett 1996;218:41-44.","journal-title":"Neurosci Lett"},{"key":"e_1_3_2_22_2","first-page":"6","volume":"26","year":"1995","unstructured":"Yamasaki Y, Matsuura N, Shozuhara H, Onodera H, Itoyama Y, Kogure K. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 1995;26:676-680.","journal-title":"Stroke"},{"key":"e_1_3_2_23_2","first-page":"2","volume":"29","year":"1992","unstructured":"Relton JK, Rothwell NJ. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res Bull 1992;29:243-246.","journal-title":"Brain Res Bull"},{"key":"e_1_3_2_24_2","first-page":"2","volume":"138","year":"1996","unstructured":"Relton JK, Martin D, Thompson RC, Russell DA. Peripheral administration of interleukin-1 receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat. Exp Neurol 1996;138:206-213.","journal-title":"Exp Neurol"},{"key":"e_1_3_2_25_2","first-page":"3","volume":"144","year":"1990","unstructured":"Gauldie J, Northemann W, Fey GH. IL-6 functions as an exocrine hormone in inflammation. Hepatocytes undergoing acute phase responses require exogenous IL-6. J Immunol 1990;144:3804-3808.","journal-title":"J Immunol"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1139\/y91-001"},{"key":"e_1_3_2_27_2","first-page":"3","volume":"101","year":"1998","unstructured":"Xing Z, Gauldie J, Cox G, et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998;101:311-320.","journal-title":"J Clin Invest"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.26.1.1"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(94)90044-2"},{"key":"e_1_3_2_30_2","first-page":"1","volume":"17","year":"1995","unstructured":"Baggiolini M, Loetscher P, Moser B. Interleukin-8 and the chemokine family. Int J Immunopharmacol 1995;17:103-108.","journal-title":"Int J Immunopharmacol"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.29.1.4"},{"key":"e_1_3_2_32_2","first-page":"1","volume":"77","year":"1997","unstructured":"Matsumoto T, Ikeda K, Mukaida N, et al. Prevention of cerebral edema and infarct in cerebral reperfusion injury by an antibody to interleukin-8. Lab Invest 1997;77:119-125.","journal-title":"Lab Invest"},{"key":"e_1_3_2_33_2","first-page":"7","volume":"71","year":"1993","unstructured":"Smith CW. Endothelial adhesion molecules and their role in inflammation. Can J Physiol Pharmacol 1993;71:76-87.","journal-title":"Can J Physiol Pharmacol"},{"key":"e_1_3_2_34_2","first-page":"3","volume":"45","year":"1994","unstructured":"Bevilacqua MP, Nelson RM, Mannori G, Cecconi O. Endothelial-leukocyte adhesion molecules in human disease. Annu Rev Med 1994;45:361-378.","journal-title":"Annu Rev Med"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90564-F"},{"key":"e_1_3_2_36_2","first-page":"4","volume":"346","year":"1990","unstructured":"Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-434.","journal-title":"Nature"},{"key":"e_1_3_2_37_2","first-page":"2","volume":"26","year":"1995","unstructured":"Clark WM, Lauten JD, Lessov N, Woodward W, Coull BM. Time course of ICAM-1 expression and leukocyte subset infiltration in rat forebrain ischemia. Mol Chem Neuropathol 1995;26:213-230.","journal-title":"Mol Chem Neuropathol"},{"key":"e_1_3_2_38_2","first-page":"2","volume":"25","year":"1994","unstructured":"Okada Y, Copeland BR, Mori E, Tung MM, Thomas WS, del Zoppo GJ. P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion. Stroke 1994;25:202-211.","journal-title":"Stroke"},{"key":"e_1_3_2_39_2","first-page":"9","volume":"94","year":"1996","unstructured":"Lindsberg PJ, Carpen O, Paetau A, Karjalainen-Lindsberg ML, Kaste M. Endothelial ICAM-1 expression associated with inflammatory cell response in human ischemic stroke. Circulation 1996;94:939-945.","journal-title":"Circulation"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.25.1.1"},{"key":"e_1_3_2_41_2","first-page":"1","volume":"144","year":"1994","unstructured":"Garcia JH, Liu KF, Yoshida Y, Lian J, Chen S, del Zoppo GJ. Influx of leukocytes and platelets in an evolving brain infarct(Wistar rat). Am J Pathol 1994;144:188-199.","journal-title":"Am J Pathol"},{"key":"e_1_3_2_42_2","first-page":"2","volume":"17","year":"1986","unstructured":"Hallenbeck JM, Dutka AJ, Tanishima T, et al. Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period. Stroke 1986;17:246-253.","journal-title":"Stroke"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.22.1.1"},{"key":"e_1_3_2_44_2","first-page":"2","volume":"16","year":"1985","unstructured":"Pozzilli C, Lenzi GL, Argentino C, et al. Imaging of leukocytic infiltration in human cerebral infarcts. Stroke 1985;16:251-255.","journal-title":"Stroke"},{"key":"e_1_3_2_45_2","first-page":"2","volume":"45","year":"1996","unstructured":"Murota S, Fujita H, Wakabayashi Y, Morita I. Cell adhesion molecule mediates endothelial cell injury caused by activated neutrophils. Keio J Med 1996;45:207-211.","journal-title":"Keio J Med"},{"key":"e_1_3_2_46_2","first-page":"3","volume":"320","year":"1989","unstructured":"Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-376.","journal-title":"N Engl J Med"},{"key":"e_1_3_2_47_2","first-page":"1","volume":"8","year":"1996","unstructured":"Akopov S, Sercombe R, Seylaz J. Cerebrovascular reactivity: role of endothelium\/platelet\/leukocyte interactions. Cerebrovasc Brain Metab Rev 1996;8:11-94.","journal-title":"Cerebrovasc Brain Metab Rev"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00910714"},{"key":"e_1_3_2_49_2","first-page":"2","volume":"26","year":"1995","unstructured":"Hamann GF, Okada Y, Fitridge R, del Zoppo GJ. Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. Stroke 1995;26:2120-2126.","journal-title":"Stroke"},{"key":"e_1_3_2_50_2","unstructured":"Abbas AK Lichtman AH Pober JS. Cytokines. In: Cellular and molecular immunology. 3rd ed. Philadelphia: WB Saunders 1997:249-277."},{"key":"e_1_3_2_51_2","first-page":"3","volume":"20","year":"1989","unstructured":"Dutka AJ, Kochanek PM, Hallenbeck JM. Influence of granulocytopenia on canine cerebral ischemia induced by air embolism. Stroke 1989;20:390-395.","journal-title":"Stroke"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410390104"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410350704"},{"key":"e_1_3_2_54_2","first-page":"6","volume":"75","year":"1991","unstructured":"Clark WM, Madden KP, Rothlein R, Zivin JA. Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion molecule. J Neurosurg 1991;75:623-627.","journal-title":"J Neurosurg"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.1.1"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.26.1.1"},{"key":"e_1_3_2_57_2","first-page":"7","volume":"237","year":"1995","unstructured":"del Zoppo GJ. Why do all drugs work in animals but none in stroke patients? 1: Drugs promoting cerebral blood flow. J Intern Med 1995;237:79-88.","journal-title":"J Intern Med"},{"key":"e_1_3_2_58_2","first-page":"8","volume":"237","year":"1995","unstructured":"Grotta J. Why do all drugs work in animals but none in stroke patients? 2: Neuroprotective therapy. J Intern Med 1995;237:89-94.","journal-title":"J Intern Med"},{"key":"e_1_3_2_59_2","unstructured":"Abbas AK Lichtman AH Pober JS. Antibodies and antigens. In: Cellular and molecular immunology. 3rd ed. Philadelphia: WB Saunders 1997:37-65."},{"key":"e_1_3_2_60_2","first-page":"2","volume":"152","year":"1994","unstructured":"Rothlein R, Kishimoto TK, Mainolfi E. Cross-linking of ICAM-1 induces co-signaling of an oxidative burst from mononuclear leukocytes. J Immunol 1994;152:2488-2495.","journal-title":"J Immunol"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.29.1.2"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004647-199601000-00001"},{"key":"e_1_3_2_63_2","first-page":"8","volume":"37","year":"1995","unstructured":"Beamer NB, Coull BM, Clark WM, Hazel JS, Silberger JR. Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol 1995;37:800-805.","journal-title":"Ann Neurol"},{"key":"e_1_3_2_64_2","first-page":"2","volume":"234","year":"1997","unstructured":"Loddick SA, Wong ML, Bongiorno PB, Gold PW, Licinio J, Rothwell NJ. Endogenous interleukin-1 receptor antagonist is neuroprotective. Biochem Biophys Res Commun 1997;234:211-215.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.51.3_Suppl_3.S62","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T17:52:23Z","timestamp":1711648343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.51.3_Suppl_3.S62"}},"subtitle":["Utility of pursuing anti-adhesion molecule therapy"],"short-title":[],"issued":{"date-parts":[[1998,9]]},"references-count":63,"journal-issue":{"issue":"3_suppl_3","published-print":{"date-parts":[[1998,9]]}},"alternative-id":["10.1212\/WNL.51.3_Suppl_3.S62"],"URL":"https:\/\/doi.org\/10.1212\/wnl.51.3_suppl_3.s62","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,9]]}}}